Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Observe Medical ASA ( (DE:OM50) ).
Observe Medical ASA has entered into an investment agreement with Songa Capital AS to issue 20 million new shares, raising NOK 10 million. This private placement, representing 17.83% of the company’s outstanding shares, will provide necessary working capital for product development and production ramp-up, while bringing in the Blystad Group as a significant shareholder. The board believes the transaction is fair and will not result in unequal treatment of existing shareholders.
More about Observe Medical ASA
Observe Medical is a Nordic medtech company that develops, markets, and sells innovative medical technology products globally. The company focuses on improving patient welfare and clinical data accuracy, primarily through products in urine measurement and ultrasound, leveraging its expertise in sales and commercialization.
Average Trading Volume: 221,458
Current Market Cap: NOK90.31M
See more insights into OM50 stock on TipRanks’ Stock Analysis page.